Tredegar (TG) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Q1 2025 net income from continuing operations was $0.7M ($0.02/share), down from $2.6M ($0.08/share) in Q1 2024, while total net income including discontinued operations rose to $10.1M from $3.3M year-over-year.
Sale of the Terphane business completed in Q4 2024, with $9.8M in post-closing proceeds received in Q1 2025 and results now reported as discontinued operations.
Aluminum Extrusions segment saw strong order growth, with net new orders up 36% year-over-year and open orders at a two-year high, despite margin pressures.
PE Films segment delivered higher EBITDA from ongoing operations, driven by increased surface protection film sales and improved cost structure.
Section 232 tariffs on aluminum imports increased to 25% in March 2025, aiding domestic market share and recovery in specialty products.
Financial highlights
Q1 2025 sales were $164.7M, up 14.4% from $144.0M in Q1 2024; net income was $10.1M, up from $3.3M, primarily due to a $9.4M gain from discontinued operations.
Gross profit margin declined to 14.3% from 16.6% year-over-year, mainly due to lower spread in Aluminum Extrusions and higher variable costs.
EBITDA from ongoing operations: Aluminum Extrusions $9.2M (down 27%), PE Films $7.5M (up 8.9%) compared to Q1 2024.
Net cash used in operating activities was $5.0M, an improvement from $7.7M used in Q1 2024; cash and equivalents at quarter-end were $3.7M.
Net debt at March 31, 2025 was $52.9M, down from $54.8M at year-end 2024.
Outlook and guidance
Aluminum Extrusions expects continued recovery, with projected 2025 capital expenditures of $17M and depreciation of $16M.
PE Films projects 2025 capital expenditures of $3M and depreciation of $5M; demand for surface protection films remains robust, though consumer electronics tariffs pose uncertainty.
Management believes current liquidity and borrowing capacity are sufficient for at least the next 12 months.
Management expects PE Films performance to normalize after an exceptional Q1; no adverse tariff impact on demand yet, but situation is fluid.
Latest events from Tredegar
- 2025 saw robust earnings growth, improved leverage, and strong segment performance amid tariff challenges.TG
Q4 202511 Mar 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor, with strong governance focus.TG
Proxy Filing2 Dec 2025 - Virtual meeting on May 9, 2025, to vote on directors, pay, and auditor ratification.TG
Proxy Filing2 Dec 2025 - Q3 2025 delivered strong profit and EBITDA growth, led by Aluminum Extrusions and lower net debt.TG
Q3 20252 Dec 2025 - Net income and EBITDA fell in Q2 2025 as tariffs and inefficiencies pressured results.TG
Q2 20258 Oct 2025 - Improved Q3 results, Terphane sale, and lower leverage amid ongoing margin pressures.TG
Q3 202413 Jun 2025 - Q2 2024 net income rebounded to $8.8M with broad EBITDA gains and key regulatory decisions ahead.TG
Q2 202413 Jun 2025 - Tredegar posts strong EBITDA growth and sharp debt reduction, returning to profitability in 2024.TG
Q4 20245 Jun 2025